QSI
Medical Devices · Healthcare
CEO, Board Member, Chairman
Board Member
Quantum-Si Inc (QSI)Chairman
Quantum-Si Inc (QSI)Chairman
Butterfly Network, Inc. (BFLY)Board Member
Butterfly Network, Inc. (BFLY)Equibles does not estimate personal net worth.
Get an email with a short summary when Quantum-Si Inc publishes a filing, an earnings call transcript or a press release.
Get QSI alertsJonathan M. Rothberg is recorded as CEO, Board Member and Chairman at Quantum-Si Inc (QSI), CEO at Butterfly Network, Inc. (BFLY) since December 6, 2022 and Chairman and Board Member at Butterfly Network, Inc. (BFLY) since February 12, 2021. The newest filing on record that lists Jonathan M. Rothberg as Board Member at Butterfly Network, Inc. (BFLY) is dated April 27, 2026. The newest filing on record that lists Jonathan M. Rothberg as Chairman at Butterfly Network, Inc. (BFLY) is dated May 2, 2022. Butterfly Network, Inc. reported in an 8-K filed December 22, 2023 that Jonathan M. Rothberg resigned as Chair of the Nominating and Governance Committee, effective December 21, 2023. Quantum-Si Inc reported in an 8-K filed June 15, 2021 that Jonathan M. Rothberg was appointed Executive Chairman of the Board, effective June 10, 2021. Butterfly Network, Inc. reported in an 8-K filed February 16, 2021 that Jonathan M. Rothberg was appointed director, effective February 12, 2021. The proxy statement of Butterfly Network, Inc. reports total compensation of $217,498 for Jonathan M. Rothberg in fiscal 2022. Jonathan M. Rothberg has spoken on 4 earnings calls across 1 company, most recently for Quantum-Si Inc on November 7, 2022. Quantum-Si Inc is classified in the Medical Devices industry within the Healthcare sector. Butterfly Network, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Quantum-Si Inc includes Jeffrey Hawkins (CEO and Board Member), John Stark (CEO and Board Member), Jonathan M. Rothberg, Ph.D. (CEO, Chairman and Board Member) and 7 others.
“On December 21, 2023, the Board also appointed Dr. Erica Shwartz, M.D., J.D., M.P.H. as Chair of the Nominating and Governance Committee and Jonathan Rothberg, Ph.D. has stepped down from his role as Chair of the committee.”
“WHEREAS, on and after June 10, 2021 (the “Effective Date”), Dr. Rothberg will serve on the Board of Directors of the Company (the “Board”), and will serve as the Executive Chairman of the Board, in each case, subject to his election by the Company’s shareholders;”
“As a testament to the promise of our pioneering work, Quantum-Si’s next-generation single-molecule protein sequencing technology was recently published in a major peer-reviewed journal.”
“In today’s call, we will provide a business update and present our second quarter financial performance and outlook for 2022. We will then open the line for questions.”
“In today's call, we will provide our business update and present our first quarter financial performance and outlook for 2022. We will then open the lines for questions.”
“We're excited to discuss the progress that Quantum-Si has made over the last two months as we work to commercialize our single molecule protein sequencing system.”
2022-12-06–present
2021-02-12–present
Last confirmed May 2, 2022
2021-02-12–present
Last confirmed April 27, 2026
Start not stated–2023-04-24
QSI
Medical Devices · Healthcare
CEO, Board Member, Chairman
Medical Devices · Healthcare
CEO, Chairman, Board Member
2021-02-12–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Butterfly Network, Inc. (BFLY) | Former Interim Chief Executive Officer | — | $217,498 |